Elutia grants director Neels 117,000 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Elutia Inc. director Guido J. Neels was granted options to acquire 117,000 shares of Class A Common Stock on November 10, 2026, at an exercise price of $0.93 per share; the options expire November 10, 2036. The one-time award equals 50% of the revised annual director awards and vests in full at the 2027 annual meeting, subject to continued service through that date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 117,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. On November 10, 2026, the Issuer's Board of Directors approved an increase in the grant date value of the annual equity awards granted to non-employee members of the Board to $150,000, with the grant date value of the annual equity award granted to the Executive Chairman continuing to equal 1.5 times that of the other non-employee directors, or $225,000 (the "Revised Annual Director Awards"). This option was granted on a one-time basis to the non-employee members of the Board equal to 50% of the Revised Annual Director Awards. The options vest in full on the date of the Company's 2027 annual meeting of stockholders, subject to continued service through such date.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
grant date value financial
Revised Annual Director Awards financial
vest in full financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many options did ELUT director Guido J. Neels receive, and at what exercise price?
AI-generated analysis. How Rhea-AI works. Not financial advice.